Greece & USA
Intelligencia
digital health
active
Intelligencia is an AI-driven technology company that focuses on minimizing the risk of drug development and enabling external innovation. It currently works with top-10 and mid-size global biopharmaceutical companies, smaller biotechs, prominent research centers, as well as investors in the biopharmaceutical space. With a focus on increasing R&D productivity, the company offers a suite of decision-making support solutions that enable its customers to minimize the risk of drug development, as well as streamline productivity and lower cost. Its platform allows customers to:
- Accurately and efficiently assess the probability of success of pipeline drugs, with supporting rationale;
- Unlock the optimal trial design, with comprehensive benchmarks linked to clinical trial success;
- Identify and prioritize additional potential indications to explore for each asset;
- Guide business development decisions by quickly and objectively comparing the attractiveness of external assets, based on a variety of features, including the underlying biology, clinical and regulatory data, and company characteristics; and
- Identify emerging technologies and scientific breakthroughs to gain competitive insights and enable identification of “the next big thing” early.
Visit Intelligencia's website
www.intelligencia.ai
contact
You would like to invest into the next big thing?
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.
